Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Iovance Biotherapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2025 | Traws Pharma Inc. | Grant or award | +36,943 | — | — |
| Apr 1, 2024 | Traws Pharma Inc. | Grant or award | +66,687 | — | — |
| Apr 1, 2024 | Traws Pharma Inc. | Grant or award | +67,550 | — | — |
| Apr 1, 2024 | Traws Pharma Inc. | Grant or award | +1,645,100 | — | — |
| Feb 20, 2024 | Iovance Biotherapeutics Inc. | Open-market purchase | +32,000 | $9.15 | $292,800 |
Questions about Iain D. Dukes
What boards is Iain D. Dukes on?
Iain D. Dukes sits on the boards of ImageneBio Inc., Iovance Biotherapeutics Inc. and Traws Pharma Inc.
What company is Iain D. Dukes the CEO of?
Iain D. Dukes is Chief Executive Officer of Traws Pharma Inc.
How long has Iain D. Dukes served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.